Vergnenegre, Alain <br/><br/>
Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC  [electronic resource] 

 -  Future oncology (London, England)  Feb 2020 
 - 5-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1744-8301 
<br/><br/><label>Standard No.: </label>10.2217/fon-2019-0730  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Metronomic<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--diagnosis<br/>Clinical Protocols<br/>Humans<br/>Lung Neoplasms--diagnosis<br/>Molecular Targeted Therapy<br/>Vinorelbine--administration & dosage